Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2-positive breast cancer.
Kevin Kalinsky
No relevant relationships to disclose
Dow-Chung Chi
No relevant relationships to disclose
Shing Mirn Lee
No relevant relationships to disclose
Kerin B. Adelson
No relevant relationships to disclose
Katherine D. Crew
No relevant relationships to disclose
Ellen Chuang
No relevant relationships to disclose
Della Makower
No relevant relationships to disclose
Dawn L. Hershman
No relevant relationships to disclose
Andrea Califano
No relevant relationships to disclose
Jose Silva
No relevant relationships to disclose
Matthew A. Maurer
No relevant relationships to disclose